TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), today announced that David McNally, President and CEO of the Company, will present a corporate overview at the Dawson James Securities 4th Annual Small Cap Growth Conference on Tuesday, October 30 at 11:00 a.m. Eastern time. The conference will be held October 29-30, 2018 at Wyndham Grand Hotel in Jupiter, Florida.
A copy of Mr. McNally’s presentation will be available on the Corporate Presentation page of Titan Medical’s website at www.titanmedicalinc.com/investors.
About Titan Medical
Titan Medical Inc. is focused on
research and development through to the planned commercialization of
computer-assisted robotic surgical technologies for application in
minimally invasive surgery. The Company is developing the SPORT Surgical
System, a single-port robotic surgical system. The SPORT Surgical System
is comprised of a surgeon-controlled patient cart that includes a 3D
high-definition vision system and multi-articulating instruments for
performing MIS procedures, and a surgeon workstation that provides an
advanced ergonomic interface to the patient cart and a 3D endoscopic
view inside the patient’s body. Titan intends to initially pursue
focused surgical indications for the SPORT Surgical System, which may
include one or more of gynecologic, urologic, colorectal or general
abdominal procedures.
For more information, please visit the Company’s website at www.titanmedicalinc.com.
